SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
…, KA Alluhaybi, HI Hobani, RM Alsulaiman… - Scientific reports, 2020 - nature.com
As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2,
continues to spread rapidly around the world, there is a need for well validated serological …
continues to spread rapidly around the world, there is a need for well validated serological …
Early humoral response correlates with disease severity and outcomes in COVID-19 patients
…, KA Alluhaybi, HI Hobani, RH AlHarbi, RM Alsulaiman… - Viruses, 2020 - mdpi.com
The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, continues to spread
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
Amplifying lateral flow assay signals for rapid detection of COVID‐19 specific antibodies
RY Alhabbab, MA Alfaleh, RM Alsulaiman… - Global …, 2022 - Wiley Online Library
Rapid lateral flow immune‐assays are point‐of‐care diagnostic tools that are easy to use,
cheap, and do not need centralized infrastructure. Therefore, these devices are appealing for …
cheap, and do not need centralized infrastructure. Therefore, these devices are appealing for …
DNA based vaccine expressing SARS-CoV-2 Spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model
…, MS Russell, AM Hashem, RM Alsulaiman… - Frontiers in …, 2022 - frontiersin.org
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious
vaccines are the most effective means in preventing the infections. A variety of vaccines have …
vaccines are the most effective means in preventing the infections. A variety of vaccines have …
[HTML][HTML] Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
…, SA Almahboub, MY Khan, RM Alsulaiman… - Frontiers in Molecular …, 2023 - frontiersin.org
The use of oncolytic viruses (OVs) in combination with cytokines, such as IL-12, is a
promising approach for cancer treatment that addresses the limitations of current standard …
promising approach for cancer treatment that addresses the limitations of current standard …
[HTML][HTML] A Modified Recombinant DNA-Based SARS-CoV-2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against …
…, RM Alsulaiman, EA Ghazal, M Basabrain… - Transboundary and …, 2023 - hindawi.com
The appearance of several variants of concern (VOCs) of SARS-CoV-2 affects the efficacy
of currently available vaccines and causes continuous spread and reinfection between …
of currently available vaccines and causes continuous spread and reinfection between …
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks
MA Alfaleh, RM Alsulaiman, SA Almahboub… - Antibody …, 2024 - academic.oup.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the Middle East
respiratory syndrome coronavirus (MERS-CoV) are highly pathogenic human coronaviruses (…
respiratory syndrome coronavirus (MERS-CoV) are highly pathogenic human coronaviruses (…
Multiple indirect ELISAs for serological detection of SARS-CoV-2 antibodies
…, SS Alamari, KA Alluhaybi, HI Hobani, RM Alsulaiman… - 2020 - repository.kaust.edu.sa
As the coronavirus disease 2019 (COVID-19), which is caused by the novel coronavirus
SARS-CoV-2, continues to spread rapidly around the world, there is an urgent need for …
SARS-CoV-2, continues to spread rapidly around the world, there is an urgent need for …
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients (preprint)
…, KA Alluhaybi, HI Hobani, RH AlHarbi, RM Alsulaiman… - 2020 - pesquisa.bvsalud.org
The Coronavirus Disease 2019 (COVID-19), caused by the novel SARS-CoV-2, continues
to spread globally with significantly high morbidity and mortality rates. Immunological …
to spread globally with significantly high morbidity and mortality rates. Immunological …
Gastrointestinal manifestations of COVID-19 in a single center in the Eastern Province of Saudi Arabia
…, MH Ismail, DM Alkhafaji, RM Alsulaiman… - Saudi Journal of …, 2022 - journals.lww.com
Background: Several gastrointestinal (GI) symptoms have been associated with novel
coronavirus disease-2019 (COVID-19). Their prevalence and relation to the severity and hospital …
coronavirus disease-2019 (COVID-19). Their prevalence and relation to the severity and hospital …
